Omar Adwan Explains Antibody Detection with the HI Test
Omar Adwan, Medical Laboratory Technologist of Modawah lab center, shared a post on LinkedIn:
“Hemagglutination Inhibition (HI) Test:
1. Objective
To identify and measure antibodies that inhibit the ability of viruses to agglutinate red blood cells (RBCs)
2. Principle
Certain viruses (like Influenza) have surface proteins (hemagglutinins) that cause RBCs to clump together (hemagglutination).
If a patient’s serum contains specific antibodies, they will bind to the virus and block hemagglutination.
Thus, no agglutination = positive inhibition = antibodies present.
3. Materials
Patient serum sample
Viral antigen (e.g., Influenza virus)
Red blood cells (usually chicken, guinea pig, or human O-type)
Microtiter plates (V-bottom or U-bottom)
Phosphate buffered saline (PBS)
Micropipettes
4. Procedure
- Heat inactivate the patient serum (to remove non-specific inhibitors).
- Prepare serial dilutions of serum in microtiter plate wells.
- Add a constant amount of virus antigen to each well.
- Add a standardized suspension of RBCs.
- Incubate and observe results.
5. Results
Positive (Inhibition): A clear button of RBCs at the bottom of the well (no agglutination). Indicates presence of antibodies.
Negative (No Inhibition): RBCs form a diffuse lattice across the well (agglutination occurs). No antibodies present.
The HI titer is the highest serum dilution that completely inhibits hemagglutination.
6. Uses
Diagnosis of viral infections (e.g., Influenza, Measles, Mumps, Rubella).
Measurement of antibody titers after vaccination.
Surveillance of circulating viral strains.
7. Conclusion
The HI test is a simple, sensitive, and widely used method for detecting virus-specific antibodies and plays a key role in vaccine development and viral epidemiology.”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation